Nature; February 12, 2026
On February 12, 2026, in an op-ed published in Nature, authors Lizzi C. Lee and Jing Qian examined China’s evolving position in the global pharmaceutical landscape. While trailing the US and Europe in fundamental research and multi-country clinical trials, China has emerged as a leader in drug development, manufacturing, and frontier science, prompting increased geopolitical scrutiny.
ASCO 2025 Annual Meeting; May 30-June 3, 2025
At 2025 ASCO Annual Meeting, global health leaders gathered under the banner of the Bloomberg New Economy International Cancer Coalition (‘Coalition’) to accelerate progress on one of oncology’s most persistent challenges: equitable access.
With participation from Mayo Clinic, Memorial Sloan Kettering Cancer Center, ASCO, the National Cancer Institute, and industry leaders including AstraZeneca, BMS, J&J, and Amgen, the Coalition launched its Rural America Task Force, aimed at designing scalable, cross-sector models to deliver care and clinical trials to underserved communities across the United States.
2025 Asco Annual Meeting; May 30-June 3, 2025
At the 2025 ASCO Annual Meeting in Chicago, the Bloomberg New Economy International Cancer Coalition (“the Coalition”) convened its first Pan-American Cancer Consortium, bringing together top leaders from healthcare systems across Latin America, the United States, and Canada. This follows the Coalition’s launch of its Rural America Task Force to advance equitable cancer access. The session focused on a shared commitment to scale cross-border multidisciplinary tumor boards (MDTs), close existing gaps in cancer care, and unlock new opportunities for clinical collaboration across the hemisphere.
With support from AstraZeneca and ASCO, the event marked a turning point in the Coalition’s mission to enable digital integration, regional coordination, and clinical innovation for underserved populations. As countries across the Americas move toward more interconnected healthcare, the call to action was clear – invest in partnerships, empower local institutions, and create new access points for patients around the world.
Read further coverage of the ASCO Annual Meeting on the Bloomberg New Economy website.
2025 ASCO Annual Meeting; May 30, 2025
From May 30 to June 3, 2025, under the theme “Driving Knowledge to Action: Building a Better Future,” the 2025 ASCO Annual Meeting extensively highlighted groundbreaking oncology innovations and international regulatory harmonization. Cure4Cancer movement champions and experts, including Dr. Bob Li (SVP and Global Head of Medical Affairs, Oncology at AstraZeneca, and Cure4Cancer Co-Founder) alongside Professor Yilong Wu (President of the Chinese Thoracic Oncology Group, CTONG), actively shaped pivotal discussions.
Dr. Bob Li co-launched the Pan-American Cancer Consortium, emphasizing global, cross-border collaborations to build customized cancer care systems that reflect local realities rather than exporting “one-size-fits-all” solutions. As an AstraZeneca executive, he also focused on interpreting and translating major oncology pipeline data into scalable real-world treatments to maximize patient access across diverse communities. Meanwhile, Professor Yilong Wu presented landmark results from a clinical study evaluating the novel anti-EGFR antibody HLX07 combined with serplulimab and chemotherapy, demonstrating improved median progression-free survival (PFS) as a first-line treatment for advanced squamous non-small cell lung cancer (sqNSCLC). Additionally, he provided expert medical analysis and commentary on major annual breakthroughs, specifically addressing lung cancer perioperative therapies and targeted treatment resistance.
“The future of cancer care isn’t about exporting one-size-fits-all solutions—it’s about co-creating systems that reflect local realities. This in collaboration with Bloomberg New Economy and ASCO made clear how global partnerships can power local innovation and access.”
— Dr. Bob Li, SVP Global Head of Medical Affairs, Oncology, AstraZeneca
Read the full announcement on the Bloomberg New Economy site.
Further coverage of the conference on MooMoo Technologies site.
Asia Society Policy Institute’s Center for China Analysis; March 31, 2025
The Asia Society Policy Institute’s Center for China Analysis (CCA) hosts a panel discussion on the progress of Healthy China 2030 and the Chinese government’s long-term healthcare reform plans. The conversation features Yanzhong Huang, senior fellow for Global Health at the Council on Foreign Relations; Winnie Yip, professor at the Harvard T.H. Chan School of Public Health; Chang Liu, CCA honorary fellow and CEO of ASK Health China; and Patrick Beyrer, CCA research associate. The panel explores key achievements to date, the obstacles to achieving the 2030 goals, and potential opportunities for international collaboration and innovation in the global healthcare industry. G.A. Donovan, CCA fellow, moderates the discussion.
U.S. Embassy & Consulates in Australia; February 3, 2024
The U.S. Ambassador to Australia announced a significant new initiative to highlight the work being done in both the United States and Australia to advance research, share best practices, and improve the lives of people with cancer, survivors, and their families.
The U.S.-Australia Moonshot Initiative was launched on World Cancer Day, Sunday, February 4. Ambassador to Australia Caroline Kennedy said “We know that no one country can end the fight against
“This initiative will highlight the work being done in both the United States and Australia to advance research, share best practices, and improve the lives of people with cancer, survivors, and their families.”
Read the full announcement on the U.S. Embassy & Consulates in Australia website
Bloomberg New Economy, January 30th 2024
Following President Biden and Prime Minister Albanese’s announcement of U.S.-Australia cooperation in innovative technologies, a U.S.-Australia Cancer Consortium was formed, focusing on pioneering cancer care collaboration.
Forbes China, September 2023
Forbes China announced its fourth Forbes China Healthcare Summit will take place virtually on Sept. 22, 2023 in the U.S. (Sept. 23, 2023 in China). The theme of this year’s summit will be “Advancing Global Health Equity To Cure Cancer”.
